Page 238 - Binder2

Unlike synthetic nanoparticles or purified protein shots,
plant-based tolerizing vaccines are biologically familiar,
mimicking the way the immune system evolved to interpret
harmless proteins. This helps:

• Prevent immune activation
• Promote regulatory phenotypes
• Reduce anti-drug antibodies (ADA)
• Enable long-term persistence of the therapeutic
effect

This isn’t immunosuppression.
It’s immune retraining—antigen-specific, durable, and
rooted in the body’s own logic.

A Platform for Preemption, Not Just Treatment

Tolerizing vaccines are not just a new kind of biologic.
They represent a new kind of immune medicine—with
implications far beyond autoimmune disease.

Imagine:

• Giving at-risk children oral insulin peptides to
prevent Type 1 diabetes
• Delivering gliadin antigens to young patients
genetically predisposed to celiac disease
• Desensitizing allergy sufferers with edible peanut or
dust mite proteins, without risking anaphylaxis
• Calming inflammation at the source in Crohn’s or
ulcerative colitis—without suppressing the entire
immune system

236